BrainScope’s Ahead™ EU-100 Headset Helps to Identificate Traumatic Brain Injury
Ahead™ EU-100 is a brain-computer interface in development by BrainScope Company. The product aims to aid in the assessment of head injury with the potential of early identification. The product can help patients with traumatic brain injury (TBI) including its milder forms commonly referred to as “concussion”.
The Ahead™ EU-100 is a portable, non-invasive, point of care, non-radiation emitting medical device in development that utilizes product miniaturization and advanced signal processing methods to provide an objective assessment and categorization of brain electrical activity associated with brain injury. The system consists of three main components: a hand-held device that includes software and algorithms for EEG acquisition and analysis and patient stratification, a disposable electrode headset, and a web-based capability for centralized storage and review of patient data.
“We are excited about the prospect of bringing this much needed product in development to the UK market,” said Michael Singer, CEO of BrainScope. “We have been fortunate to have the opportunity to collaborate with top UK hospitals and renowned clinical and scientific thought leaders to conduct our UK-based research. With approximately one million people each year attending the accident and emergency department in the UK following head injuries, we believe that the commercialization of this product in the UK will provide a valuable tool for clinicians in making informed decisions for triage, treatment and care of patients with suspected head injuries.”
In conjunction with the launch of the B-Ahead U.K. Clinical Trial in late spring, the company anticipates obtaining CE mark certification in the second half of 2011, which will provide European regulatory clearance to market and sell the Ahead™ EU-100 in the UK and throughout Europe. The company received a CE mark in April 2009 for the ZOOM-100DC, a first generation product that records, measures and displays EEG waveforms that are digitized and processed to produce conventional EEG measures displayed in table format.
In addition, BrainScope recently formed a UK subsidiary, BrainScope U.K. Ltd, representing the first subsidiary set up to commercialize its products outside of the United States. Also, in February 2011, the UK Intellectual Property Office granted registration of the BrainScope trademark.
BrainScope executive management will be attending the UK’s 2011 Healthcare Innovation Expo and International Business Innovation Zone (IBIZ 2011) this week.